Form 4 for ANVS Annovis Bio, Inc.
Accepted 2023-04-11 00:00:00 ET · period of report 2023-04-07 · accession 0001104659-23-044202 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-11 | 2023-04-07 | ANVS | Maccecchini Maria-Luisa | Pres, CEO, Dir, 10% | A - Grant | $12.61 | +20.0K | 1.06M | +2% | +$252.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-07 | A | A | 20,000 | $12.61 | 1,060,489 | D | — | — |